Qrg Capital Management, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Qrg Capital Management, Inc.
- $9.64 Trillion
- Q1 2025
A detailed history of Qrg Capital Management, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Qrg Capital Management, Inc. holds 4,184 shares of REGN stock, worth $2.41 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,184
Previous 20,711
79.8%
Holding current value
$2.41 Million
Previous $14.8 Billion
82.01%
% of portfolio
0.03%
Previous 0.15%
Shares
7 transactions
Others Institutions Holding REGN
# of Institutions
1,471Shares Held
85.7MCall Options Held
1.12MPut Options Held
1.35M-
Vanguard Group Inc Valley Forge, PA9.41MShares$5.42 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.86 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.26 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.78 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$2.3 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $61.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...